Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017

Name: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017
Brand: QYResearch
SKU: G1999B1582DEN
Price: 2900 USD
Availability: InStock

December 2017 | 105 pages | ID: G1999B1582DEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in these regions, from 2012 to 2022 (forecast), covering

North America
Europe
China
Japan
Southeast Asia
India

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Astellas Pharmaceuticals
Actavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Hospitals
Clinics
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017

1 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type (Product Category)
  1.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Preface
  1.2.4 Eluxadoline
  1.2.5 Alosetron
  1.2.6 Rifaximin
  1.2.7 Loperamide
  1.2.8 Diphenoxylate + Atropine
  1.2.9 Dicyclomine and Hyoscyamine
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application
  1.3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Others
1.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Region (2012-2022)
  1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)
  1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends
  2.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate
  2.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Region (2012-2017)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Region (2012-2017)
4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production and Market Share by Type (2012-2017)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2012-2017)
5.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth by Type (2012-2017)

6 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Astellas Pharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Actavis
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Pfizer
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Salix Pharmaceuticals Ltd
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 AstraZenenca
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview

8 IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MANUFACTURING COST ANALYSIS

8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) DRUGS MARKET FORECAST (2017-2022)

12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price and Trend Forecast (2017-2022)
12.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Preface
Table Major Manufacturers of Preface
Figure Product Picture of Eluxadoline
Table Major Manufacturers of Eluxadoline
Figure Product Picture of Alosetron
Table Major Manufacturers of Alosetron
Figure Product Picture of Rifaximin
Table Major Manufacturers of Rifaximin
Figure Product Picture of Loperamide
Table Major Manufacturers of Loperamide
Figure Product Picture of Diphenoxylate + Atropine
Table Major Manufacturers of Diphenoxylate + Atropine
Figure Product Picture of Dicyclomine and Hyoscyamine
Table Major Manufacturers of Dicyclomine and Hyoscyamine
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) by Applications (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Applications in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Players Product Capacity (K Units) (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity (K Units) of Key Manufacturers in 2016
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Players Product Production (K Units) (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) of Key Manufacturers (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers
Figure 2017 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Manufacturers
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers
Table 2017 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers
Table Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 3 Manufacturers
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share of Top 5 Manufacturers
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity (K Units) by Region (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share by Region (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share by Region
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) by Region (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Region
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) Market by Region (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Region (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) Market Share by Region
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth by Type (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) by Application (2012-2017)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share by Application in 2016
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Growth Rate by Application (2012-2017)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2012-2017)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2012-2017)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2012-2017)
Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2012-2017)
Figure Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2012-2017)
Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2012-2017)
Figure Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2012-2017)
Table Salix Pharmaceuticals Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2012-2017)
Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2012-2017)
Figure Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2012-2017)
Table AstraZenenca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Growth Rate (2012-2017)
Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share (2012-2017)
Figure AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2016
Table Major Buyers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table Distributors/Traders List
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) Forecast by Region (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) Forecast by Type (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Type (2017-2022)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report 2017

More Publications

Need Help?

Ask a Question

Market Reports